Raymond James Financial Inc Cytosorbents Corp Transaction History
Raymond James Financial Inc
- $264 Billion
- Q4 2024
A detailed history of Raymond James Financial Inc transactions in Cytosorbents Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 108,621 shares of CTSO stock, worth $107,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,621Holding current value
$107,534% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding CTSO
# of Institutions
59Shares Held
15.8MCall Options Held
16KPut Options Held
0-
Avenir Corp Washington, DC3.09MShares$3.06 Million0.29% of portfolio
-
Skylands Capital, LLC2.78MShares$2.75 Million0.38% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.95MShares$1.93 Million0.0% of portfolio
-
Neuberger Berman Group LLC New York, NY1.68MShares$1.67 Million0.0% of portfolio
-
Sargent Investment Group, LLC1.25MShares$1.24 Million0.18% of portfolio
About Cytosorbents Corp
- Ticker CTSO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 43,577,400
- Market Cap $43.1M
- Description
- Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...